Trial Profile
Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Dexlansoprazole 60 mg Delayed Release Capsules and Esomeprazole 40 mg Delayed Release Capsules on Bone Homeostasis in Healthy Postmenopausal Female Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Mar 2024
Price :
$35
*
At a glance
- Drugs Dexlansoprazole (Primary) ; Esomeprazole
- Indications Bleeding ulcer; Erosive oesophagitis; Gastro-oesophageal reflux; Helicobacter infections; NSAID-induced ulcer; Peptic ulcer; Zollinger-Ellison syndrome
- Focus Biomarker; Pharmacodynamics
- Sponsors Takeda
- 13 Nov 2018 Results published in the Gastroenterology
- 01 Nov 2017 Results presented at the 25th United European Gastroenterology Week
- 02 Mar 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.